Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xuefei Yan
Institution:
Crown Bioscience (China)
Observed institutions:
Royal Netherlands Academy of Arts and Sciences,
Anhui University of Traditional Chinese Medicine,
University Medical Center Utrecht,
Oncode Institute,
Crown Bioscience (China),
Beijing International Studies University
show all 6
OpenAlex ID:
A5100991706
Reproducibility Project: Cancer Biology
2013
·
Timothy M. Errington
, Alexandria Denis
, et al.
·
64
Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
2019
·
Xuefei Yan
, Beibei Tang
, et al.
·
eLife
·
35
Gambogic acid grafted low molecular weight heparin micelles for targeted treatment in a hepatocellular carcinoma model with an enhanced anti-angiogenesis effect
2017
·
Xuefei Yan
, Ye Yang
, et al.
·
International Journal of Pharmaceutics
·
35
A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology
2023
·
Xiaoxi Xu
, Shuzhong Wang
, et al.
·
PLoS ONE
·
29
PDF
The importance of human touch: How robot anthropomorphism impacts customer engagement in tourism and hospitality
2025
·
Jinwei Wang
, Zhihua Zhou
, et al.
·
Journal Of Vacation Marketing
·
7
PDF
Evaluation of efficacy and toxicity of human CD40 agonistic antibodies in C57BL/6-hCD40/hFcγRIIB HuGEMMTM
2023
·
Demi X Liu
, Kaixia Lian
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
Abstract 502: In vitro characterization of antibodies targeting the SIRPα-CD47 phagocytosis checkpoint using tumor-associated macrophages from HuGEMM™ mice
2021
·
Xuefei Yan
, Hongjuan Zhang
, et al.
·
Cancer Research
·
1
Tumor organoid and immune cell co-culture system potentiates immuno-oncology drug development
2020
·
Hongjuan Zhang
, Jun Zhou
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
Evaluation of PD-(L)1/VEGFA blockade alone or in combination with ADCs using advanced PBMC-Humanized model
2026
·
Kaixia Lian
, Sylvia Xiaoze Wang
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Translational 3D in vitro models for immunotherapy testing: from reconstituted organoid co-culture assays to autologous ex vivo patient tissues
2026
·
Saskia de Man
, Ezgi Kaya-Aksoy
, et al.
·
Frontiers in Immunology
PDF
Abstract 7274: A preclinical in vitro platform for evaluating the potency of bispecific T cell engagers in 2D and 3D models
2025
·
Xuefei Yan
, Shiqi Guo
, et al.
·
Cancer Research
Abstract 4168: BALB/c-CD3EDG HuGEMMTM mouse model for evaluation of CD3-targeted tumor immunotherapy
2023
·
Demi Xiaojuan Liu
, Kaixia Lian
, et al.
·
Cancer Research
TNFR2 HuGEMM™ murine model for evaluation of hTNFα-hTNFR2 signaling effect on induced regulatory T cell differentiation
2022
·
Demi Liu
, Xuefei Yan
·
Journal for ImmunoTherapy of Cancer
PDF
In vitro potency assays for immune checkpoint blockade using human primary cells, murine huGEMM immune cells and patient-derived tumor organoids
2020
·
Xuefei Yan
, Hongjuan Zhang
, et al.
·
Journal for ImmunoTherapy of Cancer
Abstract 4575: Efficacy proof of concept studies with universal mRNA vaccines in various mouse tumor models
2020
·
Chenyan Wu
, Tina Tingting Zhang
, et al.
·
Cancer Research
Author response: Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
2019
·
Xuefei Yan
, Beibei Tang
, et al.
·
eLife
Abstract B28: Validation and characterization of MiXeno humanized mouse models for immuno-oncology
2018
·
Lan Zhang
, Juan Zhang
, et al.
·
Cancer Immunology Research
Abstract B078: MiXenoTM: a fast and efficient humanized tumor model system for in vivo efficacy evaluation of novel immunotherapeutics
2018
·
Lan Zhang
, Juan Zhang
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
18
Citation count:
173
H-index:
5
I10-index:
4
Year
Topic
Type